Health
COVID-19 disrupting clinical trials, changing ‘essential’ cancer treatments – Mirage News
Suspended research and testing, the rise of telehealth, and new economic considerations are among the effects of COVID-19 on cancer care in Australia and…
“In light of physical distancing restrictions due to COVID-19, standard cancer procedures are being altered or delayed, including surveillance imaging; non-emergency surgical procedures; and clinical trials,” Sydney lead and health sociologist, Professor Alex Broom said.
“The suspension of clinical trials is especially detrimental for patients with rare cancers. For them, enrolling in a clinical trial for a promising new therapy may be the best option.”
Many experimental labs where materials, …
-
Business18 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business10 hours agoDicker Data rides the AI trend to double digit growth
-
Business14 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
General23 hours agoDenmark summons US envoy over suspected influence operations in Greenland